Back to trial details

Intake questionnaire

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Applying to Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus · Ypsilanti, Michigan

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Lung Non-Squamous Non-Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Ypsilanti for study visits?